- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03368456
Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention
August 26, 2022 updated by: David Cordova, University of Michigan
The study evaluates the preliminary efficacy of an innovative mobile-health (mHealth) intervention (hereon referred to as S4E) to improve human immunodeficiency virus and sexually transmitted infection testing and reduce HIV/STI risk behaviors in a clinic sample (n=100) of at-risk youth ages 14-21 living in Southeast Michigan.
A Stage I randomized control trial will be conducted to examine the preliminary efficacy of S4E, relative to Usual Care (UC), over a period of six months.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
HIV/STI and drug abuse remain significant public health priorities in the US and youth are disproportionately affected.
Youth between the ages of 15 - 24 constitute 25% of the sexually experienced population, yet account for 46% and 50% of HIV infections and new STIs, respectively.
National surveillance data indicate that youth disproportionately engage in HIV/STI risk behaviors, including condomless sex and licit and illicit drug use, which increase their risk for HIV/STI infection.
Despite the disproportionately high rates of HIV/STI infection and risk behaviors in youth, fewer than 14% report having ever been tested for HIV and many are not routinely screened for asymptomatic STIs as recommended by the Center for Disease Control.
In Southeast Michigan, HIV/STI are disproportionately high.
To address these significant public health concerns, a mobile-health (mHealth) intervention was developed for health clinic settings.
The proposed research aims to develop a cross-platform and universal version of S4E.
The cross-platform and universal version of S4E will be compatible with both IOS and Android operating systems, and multiple mobile devices, aimed at providing adolescents with ongoing access to the intervention once they leave the clinic.
The proposed research will also evaluate the preliminary efficacy of S4E to improve HIV/STI testing and reduce HIV/STI risk behaviors in a clinic sample (n=100) of at-risk youth ages 14-21 living in Southeast Michigan by conducting a Stage I RCT to examine the preliminary efficacy of S4E, relative to Usual Care, among a sample of 100 at-risk youth over six months.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ypsilanti, Michigan, United States, 48198
- Corner Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 21 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Female or male youth 14-21 years of age
- Sexually active
- Live in Southeast Michigan
- Have access to a smartphone or tablet
- Youth must see an enrolled clinician to participate in the study.
Exclusion Criteria:
- Report of prior psychiatric hospitalization by adolescent
- Visible cognitive impairment due to drug use
- Adolescent reports (tentative or firm) plans to move out of the Southeast Michigan area during the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: S4E App Intervention
Participants in the S4E condition will first receive the intervention in the waiting area via iPads provided for them.
Content includes the theoretically driven components of Storytelling for Empowerment: (a) Storytelling scenarios, (b) drug use and HIV/STI knowledge development, (c) interactive activities, (d) increasing self-efficacy to prevent/reduce sexual risk and drug use behaviors, and increase HIV/STI testing, (e) clinician-youth communication, and (f) highlighting prevention principles
|
S4E application was developed in collaboration with youth in Southeast Michigan.
S4E aims to prevent and reduce HIV/STI risk behaviors, including drug use and sexual risk behaviors, and increase HIV/STI testing among youth.
Content produced for the application is based on scientific prevention principles in conjunction with youth input.
To date, we have developed modules focused on youth alcohol & drug use, HIV & STIs and a forthcoming module on tobacco prevention and cessation.
|
|
Placebo Comparator: Usual Care Condition
Participants in Usual Care (i.e., Control Condition) will not receive the S4E intervention.
The Clinic's usual care includes a standard risk behaviors intake form, pamphlets highlighting resources, and reproductive and healthcare services.
|
Participants in Usual Care (i.e., Control Condition) will not receive the S4E intervention from the study staff.
The Clinic's usual care includes a standard risk behaviors intake form, pamphlets highlighting resources, and reproductive and healthcare services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Adolescent HIV Testing
Time Frame: baseline, 3 and 6 month post-baseline
|
Post-intervention, we will assess whether youths requested to receive HIV testing at the clinic, and at 3 and 6 months post-baseline (yes/no).
|
baseline, 3 and 6 month post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in condomless sex behaviors
Time Frame: 3 and 6 month post-baseline
|
Adolescent unsafe sexual behavior will be measured (time points 1-3) using items extracted from Jemmott, Jemmott, and Fong's Sexual Behavior instrument.
This gated instrument will assess the adolescent's past 90-day condom use, number of sexual partners, and contraceptive use (non-condom).
|
3 and 6 month post-baseline
|
|
Change in drug use behaviors
Time Frame: baseline, 3 and 6 month post-baseline
|
Licit and illicit drug use behaviors will be assessed (time points 1-3) using items from the Monitoring the Future Study.
Youth will be asked whether or not they have used licit or illicit drugs in their lifetime and the past 90 days.
Youth who report "Yes" to past 90-day sex will be asked to report the frequency of drug use before sex.
These measures have been used in our formative research.
|
baseline, 3 and 6 month post-baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Clinician-Youth Communication
Time Frame: baseline, 3 and 6 month post-baseline
|
Completed by both the clinician (α =.70) and youth (α =.69), clinician-youth communication will be assessed (time points 1-3) using items adapted from the Matched Pair Instrument (19 items; MPI).
MPI assesses process and content of communication, including verbal and action-related behaviors performed by clinicians.
Responses range from "1=strongly disagree," to "5=strongly agree," on a five-point Likert scale.
A sample statement for clinicians and youths is, "Encouraged the patient/me to express his or her/my thoughts concerning drug use behaviors."
|
baseline, 3 and 6 month post-baseline
|
|
Youth Self-Efficacy
Time Frame: baseline, 3 and 6 month post-baseline
|
Youth's self-efficacy will be assessed (time points 1-3) using two scales, including the Condom Self-Efficacy Scale (19 items, α =.85), and Drug Use Resistance Self-Efficacy (24 items, α =.98).
Responses range from "1=not sure at all," to "4=definitely sure," on a four-point Likert scale.
A sample question for the youth is, "How sure are you that you can refuse if a friend offers you marijuana at a party and you do not want it?"
|
baseline, 3 and 6 month post-baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Cordova, PhD, University of Michigan
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cordova D, Alers-Rojas F, Lua FM, Bauermeister J, Nurenberg R, Ovadje L, Fessler K, Delva J, Salas-Wright CP, Council YL. The Usability and Acceptability of an Adolescent mHealth HIV/STI and Drug Abuse Preventive Intervention in Primary Care. Behav Med. 2018 Jan-Mar;44(1):36-47. doi: 10.1080/08964289.2016.1189396. Epub 2016 Jul 15.
- Cordova D, Bauermeister JA, Fessler K, Delva J, Nelson A, Nurenberg R, Mendoza Lua F, Alers-Rojas F, Salas-Wright CP; Youth Leadership Council. A Community-Engaged Approach to Developing an mHealth HIV/STI and Drug Abuse Preventive Intervention for Primary Care: A Qualitative Study. JMIR Mhealth Uhealth. 2015 Dec 18;3(4):e106. doi: 10.2196/mhealth.4620.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2018
Primary Completion (Actual)
August 12, 2020
Study Completion (Actual)
August 12, 2020
Study Registration Dates
First Submitted
November 20, 2017
First Submitted That Met QC Criteria
December 4, 2017
First Posted (Actual)
December 11, 2017
Study Record Updates
Last Update Posted (Actual)
August 31, 2022
Last Update Submitted That Met QC Criteria
August 26, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00158089
- Previous HUM00118704 (Other Identifier: University of Michigan IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Abuse
-
Lund UniversityCompletedIntravenous Drug Abuse, S Aureus Colonization
-
Duke UniversityCompletedHealth Behavior | Opioid Use, Unspecified | Benzodiazepine Abuse | Prescription Drug Abuse (Not Dependent) | Benzodiazepine Dependent | Prescription Drug Abuse and DependencyUnited States
-
Stuart WillickSports Medicine Research and Testing Laboratory; Partnership for Clean CompetitionCompletedSports Drug Abuse | Abuse of Steroids or HormonesUnited States
-
University of Colorado, DenverCompletedMedication AbuseUnited States
-
National Health Promotion Associates, Inc.UnknownSubstance Use | Substance Abuse | Prescription Drug Abuse (Not Dependent)
-
Hasselt UniversityZiekenhuis Oost-Limburg; CAD LimburgCompleted
-
University of CopenhagenActive, not recruitingSports Drug AbuseDenmark
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)CompletedDrug Abuse PreventionUnited States
-
Association Athletes For TransparencyPartnership for Clean Competition; University of Milan School of Medicine; Centre... and other collaboratorsUnknown
-
Boston UniversityNational Institute on Drug Abuse (NIDA)WithdrawnIntravenous Drug Abuse
Clinical Trials on S4E
-
University of MichiganCompletedTobacco Use | Alcohol Use | Drug Use | Sexual Risk Behavior | Adolescent BehaviorUnited States